Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Topical therapies for rosacea.

Jennie B Nally1, Diane S Berson

  • 1Department of Dermatology, Weill Medical College of Cornell University, New York, NY 10021, USA.

Journal of Drugs in Dermatology : JDD
|February 14, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Dermatology's role in the fight against human trafficking: A report from the AAD Ad Hoc Task Force and call to action.

Journal of the American Academy of Dermatology·2023
Same author

Treatment of acne in the aesthetic patient: A round table update.

Journal of cosmetic dermatology·2023
Same author

Evidence of Barrier Deficiency in Rosacea and the Importance of Integrating OTC Skincare Products into Treatment Regimens.

Journal of drugs in dermatology : JDD·2021
Same author

Trends in Dermatologic Surgery: Results of the American Society for Dermatologic Surgery Procedure and Consumer Surveys.

Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]·2018
Same author

Guidelines of care for the management of acne vulgaris.

Journal of the American Academy of Dermatology·2016
Same author

Current Understanding of Seborrheic Keratosis: Prevalence, Etiology, Clinical Presentation, Diagnosis, and Management.

Journal of drugs in dermatology : JDD·2015
Same journal

Pigmented Basal Cell Carcinoma in Skin of Color: A Systematic Review of the Literature.

Journal of drugs in dermatology : JDD·2026
Same journal

Latin America Cutaneous Oncology Management (LACOM) II: A Practical Algorithm for Managing Skin Toxicities in Oncology Patients.

Journal of drugs in dermatology : JDD·2026
Same journal

Efficacy and Tolerability of a Topical Pigment-Correcting Serum in Melasma and Postinflammatory Hyperpigmentation.

Journal of drugs in dermatology : JDD·2026
Same journal

Decoding Sensitive Skin Syndrome: International Expert Advisory Insights on Management From India and the United States of America.

Journal of drugs in dermatology : JDD·2026
Same journal

Evaluating the Safety and Efficacy of Sirolimus Topical Gel 0.2% to Treat Acanthosis Nigricans.

Journal of drugs in dermatology : JDD·2026
Same journal

Moringa-Derived Formulations for Hair Growth, Hair Preservation, and Hair Loss: A Systematic Review.

Journal of drugs in dermatology : JDD·2026
See all related articles

Topical treatments are crucial for managing rosacea, especially papulopustular and erythematotelangiectatic types. Metronidazole, azelaic acid, and sodium sulfacetamide-sulfur are primary approved topical agents for effective rosacea symptom control.

Area of Science:

  • Dermatology
  • Cutaneous Medicine
  • Pharmacology

Background:

  • Rosacea is a chronic inflammatory skin condition with various therapeutic options.
  • Topical therapies are essential for managing specific rosacea subtypes, including papulopustular and erythematotelangiectatic rosacea.
  • Key manifestations like papules, pustules, and erythema can be effectively reduced with topical treatments.

Purpose of the Study:

  • To review the role and efficacy of primary topical agents in rosacea management.
  • To differentiate between approved and non-approved topical therapies for rosacea.

Main Methods:

  • Review of established therapeutic options for rosacea.
  • Focus on the efficacy and approval status of topical agents.
  • Analysis of scientific literature validating treatment outcomes.

Related Experiment Videos

Main Results:

  • Metronidazole, azelaic acid, and sodium sulfacetamide-sulfur are the three principal FDA-approved topical treatments for rosacea.
  • These agents have demonstrated efficacy in multiple studies for reducing rosacea symptoms.
  • Other topical agents like benzoyl peroxide, clindamycin, and retinoids are not FDA-approved for rosacea and have variable roles.

Conclusions:

  • Approved topical agents form the cornerstone of treatment for papulopustular and erythematotelangiectatic rosacea.
  • Physicians should prioritize FDA-approved topical therapies for rosacea based on clinical evidence.
  • Non-approved topical agents may be considered adjunctively but require careful patient monitoring.